길랭-바레 증후군의 임상적 스펙트럼

키워드

참고문헌 (59)

1. Yuki N, "Guillain-Barré syndrome", N Engl J Med, 366, pp.2294~2304 (2012)
2. Hughes RAC, "Guillain-Barré syndrome", Lancet, 366, pp.1653~1666 (2005)
3. Kuwabara S, "Guillain-Barré syndrome", Curr Neurol Neurosci Rep, 7, pp.57~62 (2007)
4. Vucic S, "Guillain-Barré syndrome:an update", J Clin Neurosci, 16, pp.733~741 (2009)
5. Yuki N, "Guillain-Barrésyndrome associated with normal or exaggerated tendon reflexes", Journal of neurology, 259, pp.1181~1190 (2012)
6. Asbury AK, "Assessment of current diagnostic criteria for Guillain-Barré syndrome", Annals of neurology, 27 Suppl, pp.S21~S24 (1990)
7. var JJ, "Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data", Vaccine, 29, pp.599~612 (2011)
8. van der Meché FGA, "Diagnostic and classification criteria for the Guillain-Barré syndrome", European neurology, 45, pp.133~139 (2001)
9. Feasby TE, "An acute axonal form of Guillain-Barré polyneuropathy", Brain, 109, pp.1115~1126 (1986)
10. Ho TW, "Guillain-Barré syndrome in northern China. relationship to Campylobacter jejuni infection and anti-glycolipid antibodies", Brain, 118, pp.597~605 (1995)
11. Kuwabara S, "IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome", Ann Neurol, 44, pp.202~208 (1998)
12. Yuki N, "Guillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey", Proc Jpn Acad Ser B Phys Biol Sci, 88, pp.299~326 (2012)
13. Lee SH, "Acute ophthalmoplegia (without ataxia) associated with anti-GQ1b antibody", Neurology, 71, pp.426~429 (2008)
14. Ropper AH, "Unusual clinical variants and signs in Guillain-Barre syndrome", Archives of neurology, 43, pp.1150~1152 (1986)
15. McGrogan A, "The epidemiology of Guillain-Barré syndrome worldwide: a systematic literature review", Neuroepidemiology, 32, pp.150~163 (2009)
16. Rees JH, "Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection", Ann Neurol, 38, pp.809~816 (1995)
17. Omejec G, "Retrospective analysis of Slovenian patients with Guillain-Barré syndrome", J Peripher Nerv Syst, 17, pp.217~219 (2012)
18. Blaser MJ, "Epidemiology of Campylobacter jejuni infections", Epidemiol Rev, 5, pp.157~176 (1983)
19. Geleijns K, "The occurrence of Guillain-Barré syndrome within families", Neurology, 63, pp.1747~1750 (2004)
20. Saunders M, "Familial Guillain-Barré syndrome", Lancet, 2, pp.1106~1107 (1965)
21. Bae JS, "Guillain-Barre syndrome in Asia", Journal of neurology, neurosurgery, and psychiatry (2013)
22. Kuwabara S, "Axonal Guillain-Barre syndrome:concepts and controversies", Lancet neurology, 12, pp.1180~1188 (2013)
23. Guillain G, "Les polyradiculonévrites avec dissociation alumbinocytologique et á evolution favorable. (Syndrome de Guillain et Barré.)", J belge Neurol Psychiat, pp.323~329 (1938)
24. Bickerstaff ER, "Mesencephalitis and rhombencephalitis", Br Med J, ii(4723), pp.77~81 (1951)
25. Bickerstaff ER, "Brain-stem encephalitis: further observations on a grave syndrome with benign prognosis", Br Med J, pp.1384~1387 (1957)
26. Fisher M, "An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia)", N Engl J Med, 255, pp.57~65 (1956)
27. Richter RB, "The ataxic form of polyradiculoneuritis (Landry-Guillain-Barré syndrome): clinical and pathologic observations", J Neuropathol Exp Neurol, 21, pp.171~184 (1962)
28. Ropper AH, "Further regional variants of acute immune polyneuropathy: bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness", Archives of neurology, 51, pp.671~675 (1994)
29. Jibiki T, "Guillain-Barre syndrome associated with anti-GQ1b antibody--nosological relationship between Fisher's syndrome and Guillain-Barre syndrome", Rinsho shinkeigaku = Clinical neurology, 34, pp.381~384 (1994)
30. Okuda B, "Fulminant Guillain-Barre syndrome after Campylobacter jejuni enteritis and monospecific anti-GT1a IgG antibody", Intern Med, 41, pp.889~891 (2002)
31. Miura Y, "Guillain-Barré syndrome presenting pharyngeal-cervical-brachial weakness in the recovery phase", European neurology, 48, pp.53~54 (2002)
32. Ropper AH, "The Guillain-Barré syndrome", N Engl J Med, 326, pp.1130~1136 (1992)
33. Koike H, "Clinicopathological features of acute autonomic and sensory neuropathy", Brain: a journal of neurology, 133, pp.2881~2896 (2010)
34. Koike H, "The spectrum of clinicopathological features in pure autonomic neuropathy", Journal of neurology, 259, pp.2067~2075 (2012)
35. Ohyama K, "Differential recovery in cardiac and vasomotor sympathetic functional markers in a patient with acute autonomic sensory and motor neuropathy", Intern Med, 52, pp.497~502 (2013)
36. Uncini A, "Sensory Guillain-Barré syndrome and related disorders: an attempt at systematization", Muscle &nerve, 45, pp.464~470 (2012)
37. Ito M, "Ataxic Guillain-Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum", Journal of neurology, neurosurgery, and psychiatry, 82, pp.294~299 (2011)
38. Kusunoki S, "Experimental sensory neuropathy induced by sensitization with ganglioside GD1b", Annals of neurology, 39, pp.424~431 (1996)
39. Nagai Y, "Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides", Neuroscience letters, 2, pp.107~111 (1976)
40. Yuki N, "Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside", Ann Neurol, 49, pp.712~720 (2001)
41. Susuki K, "Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons", Ann Neurol, 54, pp.383~388 (2003)
42. Yuki N, "Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome", Proc Natl Acad Sci U S A, 101, pp.11404~11409 (2004)
43. Yuki N, "Ganglioside mimicry and peripheral nerve disease", Muscle Nerve, 35, pp.691~711 (2007)
44. Sekiguchi Y, "Antiganglioside antibodies are associated with axonal Guillain-Barre syndrome:a Japanese-Italian collaborative study", Journal of neurology, neurosurgery, and psychiatry, 83, pp.23~28 (2012)
45. Ogawara K, "Axonal Guillain-Barre syndrome: relation to antiganglioside antibodies and Campylobacter jejuni infection in Japan", Ann Neurol, 48, pp.624~631 (2000)
46. Kim JK, "Acute pure motor demyelinating neuropathy with hyperreflexia and anti-GalNAc-GD1a antibodies", Clinical neurology and neurosurgery, 114, pp.1345~1347
47. Kusunoki S, "N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome", Ann Neurol, 35, pp.570~576 (1994)
48. Miyazaki T, "Guillain-Barré syndrome associated with IgG monospecific to ganglioside GD1b", Neurology, 56, pp.1227~1229 (2001)
49. Nagashima T, "Clinical correlates of serum anti-GT1a IgG antibodies", J Neurol Sci, 219, pp.139~145 (2004)
50. Kim SY, "Polycranial neuropathy and sensory ataxia with IgG anti-GD1a antibody as a variant of Guillain-Barre syndrome", J Clin Neurosci, 20, pp.473~475 (2013)
51. Bae JS, "Bilateral internal ophthalmoplegia as an initial sole manifestation of Miller Fisher syndrome", J Clin Neurosci, 16, pp.963~964 (2009)
52. 김종국, "Prevalence of Anti-Ganglioside Antibodies and Their Clinical Correlates with Guillain-Barré Syndrome in Korea: A Nationwide Multicenter Study", Journal of Clinical Neurology, 10(2), pp.94~100 (2014), 대한신경과학회[DOI]
53. Uncini A, "Electrodiagnostic criteria for Guillain-Barré syndrome: a critical revision and the need for an update. Clinical neurophysiology : official journal of the International Federation of Clinical", Neurophysiology, 123, pp.1487~1495 (2012)
54. Uncini A, "Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes", Journal of neurology, neurosurgery, and psychiatry, 81, pp.1157~1163 (2010)
55. Wakerley BR, "Pharyngeal-cervical-brachial variant of Guillain-Barré syndrome", Journal of neurology, neurosurgery, and psychiatry, 85, pp.339~344 (2014)
56. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)., "Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force", Neurology, 41, pp.617~618 (1991)
57. "European Federation of Neurological Societies", Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy:report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--First Revision, 2010, pp.15, 1~9
58. Asbury AK, "The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis", Medicine (Baltimore), 48, pp.173~215 (1969)
59. Kaida K, "Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--a review", Glycobiology, 19, pp.676~692 (2009)

관련 논문AI추천